F.L. Putnam Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.8M | Buy |
67,484
+32,693
| +94% | +$15.7M | 0.4% | 49 |
|
|
2026
Q1 | $17.1M | Buy |
34,791
+4,012
| +13% | +$2.18M | 0.25% | 77 |
|
|
2025
Q4 | $17.8M | Sell |
30,779
-677
| -2% | -$383K | 0.26% | 70 |
|
|
2025
Q3 | $15.3M | Buy |
31,456
+2,732
| +10% | +$1.27M | 0.23% | 83 |
|
|
2025
Q2 | $11.6M | Sell |
28,724
-6,931
| -19% | -$2.9M | 0.2% | 100 |
|
|
2025
Q1 | $17.7M | Sell |
35,655
-5,399
| -13% | -$2.92M | 0.33% | 64 |
|
|
2024
Q4 | $21.4M | Sell |
41,054
-15,898
| -28% | -$8.74M | 0.39% | 55 |
|
|
2024
Q3 | $27.7M | Buy |
56,952
+11,776
| +26% | +$6.97M | 0.5% | 44 |
|
|
2024
Q2 | $25M | Buy |
45,176
+8,655
| +24% | +$4.96M | 0.47% | 43 |
|
|
2024
Q1 | $21.2M | Buy |
36,521
+363
| +1% | +$204K | 0.45% | 51 |
|
|
2023
Q4 | $19.2M | Buy |
36,158
+1,413
| +4% | +$684K | 0.45% | 52 |
|
|
2023
Q3 | $17.6M | Buy |
34,745
+114
| +0.3% | +$60.7K | 0.49% | 47 |
|
|
2023
Q2 | $18.1M | Sell |
34,631
-579
| -2% | -$312K | 0.49% | 45 |
|
|
2023
Q1 | $20.3M | Sell |
35,210
-403
| -1% | -$227K | 0.66% | 38 |
|
|
2022
Q4 | $19.6M | Sell |
35,613
-215
| -0.6% | -$114K | 0.71% | 37 |
|
|
2022
Q3 | $18.2M | Buy |
35,828
+747
| +2% | +$418K | 0.71% | 37 |
|
|
2022
Q2 | $19.1M | Sell |
35,081
-1,878
| -5% | -$1.03M | 0.7% | 38 |
|
|
2022
Q1 | $21.8M | Buy |
36,959
+485
| +1% | +$279K | 0.7% | 37 |
|
|
2021
Q4 | $24.3M | Buy |
36,474
+1,640
| +5% | +$1.02M | 0.75% | 37 |
|
|
2021
Q3 | $19.9M | Buy |
34,834
+1,927
| +6% | +$1.06M | 0.68% | 43 |
|
|
2021
Q2 | $16.6M | Sell |
32,907
-3,075
| -9% | -$1.45M | 0.57% | 48 |
|
|
2021
Q1 | $16.4M | Buy |
35,982
+709
| +2% | +$338K | 0.72% | 40 |
|
|
2020
Q4 | $16.4M | Sell |
35,273
-683
| -2% | -$320K | 0.77% | 36 |
|
|
2020
Q3 | $15.9M | Sell |
35,956
-1,986
| -5% | -$821K | 0.87% | 35 |
|
|
2020
Q2 | $13.7M | Sell |
37,942
-513
| -1% | -$172K | 0.82% | 38 |
|
|
2020
Q1 | $10.9M | Buy |
38,455
+905
| +2% | +$285K | 0.83% | 38 |
|
|
2019
Q4 | $12.2M | Sell |
37,550
-4,412
| -11% | -$1.34M | 0.75% | 42 |
|
|
2019
Q3 | $12.2M | Buy |
41,962
+1,031
| +3% | +$295K | 0.86% | 34 |
|
|
2019
Q2 | $12M | Buy |
40,931
+4,873
| +14% | +$1.34M | 0.97% | 31 |
|
|
2019
Q1 | $9.87M | Buy |
36,058
+7,057
| +24% | +$1.76M | 0.83% | 38 |
|
|
2018
Q4 | $6.49M | Buy |
29,001
+810
| +3% | +$190K | 0.71% | 50 |
|
|
2018
Q3 | $6.88M | Sell |
28,191
-554
| -2% | -$127K | 0.63% | 56 |
|
|
2018
Q2 | $5.95M | Sell |
28,745
-418
| -1% | -$88.7K | 0.58% | 58 |
|
|
2018
Q1 | $6.02M | Buy |
29,163
+410
| +1% | +$86.1K | 0.55% | 62 |
|
|
2017
Q4 | $5.46M | Sell |
28,753
-1,083
| -4% | -$207K | 0.5% | 65 |
|
|
2017
Q3 | $5.64M | Buy |
+29,836
| New | +$5.4M | 0.54% | 63 |
|
|
2017
Q1 | $2.85M | Buy |
18,558
+14,971
| +417% | +$2.29M | 0.3% | 84 |
|
|
2016
Q4 | $506K | Buy |
+3,587
| New | +$529K | 0.06% | 149 |
|
Other funds holding TMO
F.L. Putnam Investment Management's TMO Position: Q2 2026 in Review
F.L. Putnam Investment Management increased its Thermo Fisher Scientific (TMO) stake by 94% in Q2 2026, buying an estimated $15.7M and bringing the position to 67,484 shares worth $33.8M. The position accounts for 0.4% of the portfolio, ranked #49.
F.L. Putnam Investment Management first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. 1,732 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- F.L. Putnam Investment Management held 67,484 shares of Thermo Fisher Scientific worth $33.8M as of Q2 2026.
- F.L. Putnam Investment Management bought 32,693 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.7M.
- Thermo Fisher Scientific made up 0.4% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #49 holding.
- F.L. Putnam Investment Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- 1,732 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.